SGS SA (OTCMKTS:SGSOY – Get Free Report) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 6,500 shares, a growth of 2,066.7% from the October 31st total of 300 shares. Based on an average daily volume of 180,200 shares, the short-interest ratio is presently 0.0 days.
SGS Stock Performance
Shares of OTCMKTS SGSOY remained flat at $9.73 during midday trading on Wednesday. The stock had a trading volume of 90,383 shares, compared to its average volume of 87,389. The company’s 50 day moving average is $10.65 and its 200 day moving average is $10.14. The company has a quick ratio of 1.09, a current ratio of 1.23 and a debt-to-equity ratio of 4.45. SGS has a 52-week low of $8.18 and a 52-week high of $11.54.
Analysts Set New Price Targets
SGSOY has been the topic of several analyst reports. Royal Bank of Canada cut SGS from a “sector perform” rating to an “underperform” rating in a research report on Monday, October 21st. BNP Paribas raised shares of SGS to a “hold” rating in a research note on Monday, September 30th.
About SGS
SGS SA provides inspection, testing, and verification services in Europe, Africa, the Middle East, the Americas, and the Asia Pacific. It operates in five segments: Connectivity & Products, Health & Nutrition, Industries & Environment, Natural Resources, and Business Assurance. The company provides laboratory testing, product inspection and consulting, process assessment, technical and transactional assistance; and automotive, connectivity, softlines and accessories, and hardgoods, toys, and juvenile products, as well as government and trade facilitation services.
See Also
- Five stocks we like better than SGS
- How to Buy Cheap Stocks Step by Step
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the Shanghai Stock Exchange Composite Index?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for SGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SGS and related companies with MarketBeat.com's FREE daily email newsletter.